T3D Therapeutics

Small Alzheimer's hopeful biotech nabs $15M series B

A small private biotech has raised a modest series B as it continues to test its idea that the memory-wasting disease can be beaten back by focusing o

Ben Adams Nov 4, 2019 9:15am